Bercker Sven, Weber-Carstens Steffen, Deja Maria, Grimm Claudia, Wolf Steffen, Behse Friedrich, Busch Thilo, Falke Konrad J, Kaisers Udo
Department of Anesthesiology and Intensive Care Medicine, Charité, Campus Virchow-Klinikum, University Medical Center, Berlin, Germany.
Crit Care Med. 2005 Apr;33(4):711-5. doi: 10.1097/01.ccm.0000157969.46388.a2.
Critical illness polyneuropathy/myopathy (CIP/CIM) is frequently described in critically ill patients who survive severe sepsis. Clinically relevant paresis is major symptom of CIP/CIM. We aimed at determining risk factors and diagnostic value of electrophysiologic testing for CIP/CIM in patients with acute respiratory distress syndrome (ARDS).
Single-center, retrospective analysis, using charts.
University medical center.
Fifty consecutive ARDS patients in our intensive care unit.
Patient characteristics and clinical course were analyzed. All patients received early electrophysiologic testing. CIP/CIM was diagnosed by the presence of clinical relevant paresis.
Clinically relevant paresis was confirmed in 27 ARDS patients (60%), whereas in 18 patients no paresis was determined (controls); five patients died before clinical assessment of paresis was feasible. Patients with paresis were older, had more days on mechanical ventilation, and had increased intensive care unit length of stay compared with controls. Patients who developed paresis had elevated daily peak blood glucose levels during 28 days of intensive care unit treatment: 166 (134, 200) mg/dL in CIP/CIM patients vs. 144 (132, 161) mg/dL in controls (median, quartiles). Twenty-five of 27 patients with paresis revealed reduced motor unit potentials, fibrillation potentials, or positive sharp waves on early electrophysiologic testing indicating CIP/CIM, whereas 16 of 18 control patients did not.
In ARDS patients, paresis is a frequent complication causing prolonged mechanical ventilation and intensive care unit length of stay. An association between hyperglycemia and CIP/CIM has been found. However, since this is a retrospective survey, a causal relation is not clearly supported. In this study, the use of early electrophysiologic testing in ARDS patients was a valuable diagnostic tool for detecting CIP/CIM.
危重病性多发性神经病/肌病(CIP/CIM)在严重脓毒症存活的危重病患者中经常被描述。临床相关的轻瘫是CIP/CIM的主要症状。我们旨在确定急性呼吸窘迫综合征(ARDS)患者中CIP/CIM的危险因素及电生理检测的诊断价值。
单中心回顾性分析,采用病历资料。
大学医学中心。
我们重症监护病房连续收治的50例ARDS患者。
分析患者特征及临床病程。所有患者均接受早期电生理检测。CIP/CIM通过临床相关轻瘫的存在来诊断。
27例ARDS患者(60%)确诊有临床相关轻瘫,18例患者未发现轻瘫(对照组);5例患者在轻瘫临床评估可行前死亡。与对照组相比,有轻瘫的患者年龄更大,机械通气天数更多,重症监护病房住院时间更长。在重症监护病房治疗的28天内,发生轻瘫的患者每日血糖峰值水平升高:CIP/CIM患者为166(134,200)mg/dL,对照组为144(132,161)mg/dL(中位数,四分位数)。27例有轻瘫的患者中有25例在早期电生理检测中显示运动单位电位降低、纤颤电位或正锐波,提示CIP/CIM,而对照组18例患者中有16例未出现上述情况。
在ARDS患者中,轻瘫是一种常见并发症,可导致机械通气时间延长和重症监护病房住院时间延长。已发现高血糖与CIP/CIM之间存在关联。然而,由于这是一项回顾性调查,因果关系未得到明确支持。在本研究中,对ARDS患者进行早期电生理检测是检测CIP/CIM的一项有价值的诊断工具。